Cervical cancer vaccines available in 2007

被引：33

作者：

Andrawiss, M

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：949 / 950

页数：2

共 4 条

[1] Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
Goldie, SJ
Kohli, M
Grima, D
Weinstein, MC
Wright, TC
Bosch, FX
Franco, E
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08): : 604 - 615
[2] Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Harper, DM
Franco, EL
Wheeler, C
Ferris, DG
Jenkins, D
Schuind, A
Zahaf, T
Innis, B
Naud, P
De Carvalho, NS
Roteli-Martins, CM
Teixeira, J
Blatter, MM
Korn, AP
Quint, W
Dubin, G
[J]. LANCET, 2004, 364 (9447) : 1757 - 1765
[3] Potential health and economic impact of adding a human papillomavirus vaccine to screening programs
Kulasingam, SL
Myers, ER
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (06): : 781 - 789
[4] Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Villa, LL
Costa, RLR
Petta, CA
Andrade, RP
Ault, KA
Giuliano, AR
Wheeler, CM
Koutsky, LA
Malm, C
Lehtinen, M
Skjeldestad, FE
Olsson, SE
Steinwall, M
Brown, DR
Kurman, R
Ronnett, BM
Stoler, MH
Ferenczy, A
Harper, DM
Tamms, GM
Yu, J
Lupinacci, L
Railkar, R
Taddeo, FJ
Jansen, KU
Esser, MT
Sings, HL
Saah, AJ
Lupinacci, L
[J]. LANCET ONCOLOGY, 2005, 6 (05) : 271 - 278